Literature DB >> 25699603

D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections.

César de la Fuente-Núñez1, Fany Reffuveille1, Sarah C Mansour1, Shauna L Reckseidler-Zenteno2, Diego Hernández2, Gilles Brackman3, Tom Coenye3, Robert E W Hancock4.   

Abstract

In many infections, bacteria form surface-associated communities known as biofilms that are substantially more resistant to antibiotics than their planktonic counterparts. Based on the design features of active antibiofilm peptides, we made a series of related 12-amino acid L-, D- and retro-inverso derivatives. Specific D-enantiomeric peptides were the most potent at inhibiting biofilm development and eradicating preformed biofilms of seven species of wild-type and multiply antibiotic-resistant Gram-negative pathogens. Moreover, these peptides showed strong synergy with conventional antibiotics, reducing the antibiotic concentrations required for complete biofilm inhibition by up to 64-fold. As shown previously for 1018, these D-amino acid peptides targeted the intracellular stringent response signal (p)ppGpp. The most potent peptides DJK-5 and DJK-6 protected invertebrates from lethal Pseudomonas aeruginosa infections and were considerably more active than a previously described L-amino acid peptide 1018. Thus, the protease-resistant peptides produced here were more effective both in vitro and in vivo.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25699603      PMCID: PMC4362967          DOI: 10.1016/j.chembiol.2015.01.002

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  42 in total

Review 1.  Biofilm formation as microbial development.

Authors:  G O'Toole; H B Kaplan; R Kolter
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

2.  (p)ppGpp regulates type 1 fimbriation of Escherichia coli by modulating the expression of the site-specific recombinase FimB.

Authors:  Anna Aberg; Victoria Shingler; Carlos Balsalobre
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

Review 3.  Maintenance of C. elegans.

Authors:  Theresa Stiernagle
Journal:  WormBook       Date:  2006-02-11

Review 4.  (p)ppGpp: still magical?

Authors:  Katarzyna Potrykus; Michael Cashel
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

Review 5.  Pseudomonas aeruginosa: all roads lead to resistance.

Authors:  Elena B M Breidenstein; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Trends Microbiol       Date:  2011-06-12       Impact factor: 17.079

Review 6.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

7.  Listeria monocytogenes relA and hpt mutants are impaired in surface-attached growth and virulence.

Authors:  Clare M Taylor; Mark Beresford; Harry A S Epton; David C Sigee; Gilbert Shama; Peter W Andrew; Ian S Roberts
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

8.  Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Authors:  George Sakoulas; Cheryl Y Okumura; Wdee Thienphrapa; Joshua Olson; Poochit Nonejuie; Quang Dam; Abhay Dhand; Joseph Pogliano; Michael R Yeaman; Mary E Hensler; Arnold S Bayer; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

Review 9.  Cyclic di-GMP: the first 25 years of a universal bacterial second messenger.

Authors:  Ute Römling; Michael Y Galperin; Mark Gomelsky
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

10.  Regulation of the stringent response is the essential function of the conserved bacterial G protein CgtA in Vibrio cholerae.

Authors:  David M Raskin; Nicholas Judson; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more
  103 in total

1.  Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome.

Authors:  William Klare; Theerthankar Das; Amaye Ibugo; Edwina Buckle; Mike Manefield; Jim Manos
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Novel Antimicrobial Peptides Formulated in Chitosan Matrices are Effective Against Biofilms of Multidrug-Resistant Wound Pathogens.

Authors:  Jennifer A Neff; Danir F Bayramov; Esha A Patel; Jing Miao
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

3.  Repurposing a peptide toxin from wasp venom into antiinfectives with dual antimicrobial and immunomodulatory properties.

Authors:  Osmar N Silva; Marcelo D T Torres; Jicong Cao; Elaine S F Alves; Leticia V Rodrigues; Jarbas M Resende; Luciano M Lião; William F Porto; Isabel C M Fensterseifer; Timothy K Lu; Octavio L Franco; Cesar de la Fuente-Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-12       Impact factor: 11.205

Review 4.  Microtiter plate assays to assess antibiofilm activity against bacteria.

Authors:  Evan F Haney; Michael J Trimble; Robert E W Hancock
Journal:  Nat Protoc       Date:  2021-04-28       Impact factor: 13.491

Review 5.  Control of Biofilm Formation: Antibiotics and Beyond.

Authors:  Ammar Algburi; Nicole Comito; Dimitri Kashtanov; Leon M T Dicks; Michael L Chikindas
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

Review 6.  New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics.

Authors:  Mariam Taha; Hesham Abdelbary; F Patrick Ross; Alberto V Carli
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

7.  Helicobacter pylori Biofilm Formation Is Differentially Affected by Common Culture Conditions, and Proteins Play a Central Role in the Biofilm Matrix.

Authors:  Ian H Windham; Stephanie L Servetas; Jeannette M Whitmire; Daniel Pletzer; Robert E W Hancock; D Scott Merrell
Journal:  Appl Environ Microbiol       Date:  2018-07-02       Impact factor: 4.792

8.  Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections.

Authors:  César de la Fuente-Núñez; Robert E W Hancock
Journal:  Postdoc J       Date:  2015-02

Review 9.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

10.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.